Cargando…

DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo

INTRODUCTION: B cells have many different roles in systemic lupus erythematosus (SLE), ranging from autoantigen recognition and processing to effector functions (for example, autoantibody and cytokine secretion). Recent studies have shown that intracellular nucleic acid-sensing receptors, Toll-like...

Descripción completa

Detalles Bibliográficos
Autores principales: Lenert, Petar, Yasuda, Kei, Busconi, Liliana, Nelson, Patrice, Fleenor, Courtney, Ratnabalasuriar, Radhika S, Nagy, Peter L, Ashman, Robert F, Rifkin, Ian R, Marshak-Rothstein, Ann
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714127/
https://www.ncbi.nlm.nih.gov/pubmed/19476613
http://dx.doi.org/10.1186/ar2710
_version_ 1782169642118152192
author Lenert, Petar
Yasuda, Kei
Busconi, Liliana
Nelson, Patrice
Fleenor, Courtney
Ratnabalasuriar, Radhika S
Nagy, Peter L
Ashman, Robert F
Rifkin, Ian R
Marshak-Rothstein, Ann
author_facet Lenert, Petar
Yasuda, Kei
Busconi, Liliana
Nelson, Patrice
Fleenor, Courtney
Ratnabalasuriar, Radhika S
Nagy, Peter L
Ashman, Robert F
Rifkin, Ian R
Marshak-Rothstein, Ann
author_sort Lenert, Petar
collection PubMed
description INTRODUCTION: B cells have many different roles in systemic lupus erythematosus (SLE), ranging from autoantigen recognition and processing to effector functions (for example, autoantibody and cytokine secretion). Recent studies have shown that intracellular nucleic acid-sensing receptors, Toll-like receptor (TLR) 7 and TLR9, play an important role in the pathogenesis of SLE. Dual engagement of rheumatoid factor-specific AM14 B cells through the B-cell receptor (BCR) and TLR7/9 results in marked proliferation of autoimmune B cells. Thus, strategies to preferentially block innate activation through TLRs in autoimmune B cells may be preferred over non-selective B-cell depletion. METHODS: We have developed a new generation of DNA-like compounds named class R inhibitory oligonucleotides (INH-ODNs). We tested their effectiveness in autoimmune B cells and interferon-alpha-producing dendritic cells in vitro and in lupus-prone MRL-Fas(lpr/lpr )mice in vivo. RESULTS: Class R INH-ODNs have 10- to 30-fold higher inhibitory potency when autoreactive B cells are synergistically activated through the BCR and associated TLR7 or 9 than when stimulation occurs via non-BCR-engaged TLR7/9. Inhibition of TLR9 requires the presence of both CCT and GGG triplets in an INH-ODN, whereas the inhibition of the TLR7 pathway appears to be sequence-independent but dependent on the phosphorothioate backbone. This difference was also observed in the MRL-Fas(lpr/lpr )mice in vivo, where the prototypic class R INH-ODN was more effective in curtailing abnormal autoantibody secretion and prolonging survival. CONCLUSIONS: The increased potency of class R INH-ODNs for autoreactive B cells and dendritic cells may be beneficial for lupus patients by providing pathway-specific inhibition yet allowing them to generate protective immune response when needed.
format Text
id pubmed-2714127
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27141272009-07-22 DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo Lenert, Petar Yasuda, Kei Busconi, Liliana Nelson, Patrice Fleenor, Courtney Ratnabalasuriar, Radhika S Nagy, Peter L Ashman, Robert F Rifkin, Ian R Marshak-Rothstein, Ann Arthritis Res Ther Research Article INTRODUCTION: B cells have many different roles in systemic lupus erythematosus (SLE), ranging from autoantigen recognition and processing to effector functions (for example, autoantibody and cytokine secretion). Recent studies have shown that intracellular nucleic acid-sensing receptors, Toll-like receptor (TLR) 7 and TLR9, play an important role in the pathogenesis of SLE. Dual engagement of rheumatoid factor-specific AM14 B cells through the B-cell receptor (BCR) and TLR7/9 results in marked proliferation of autoimmune B cells. Thus, strategies to preferentially block innate activation through TLRs in autoimmune B cells may be preferred over non-selective B-cell depletion. METHODS: We have developed a new generation of DNA-like compounds named class R inhibitory oligonucleotides (INH-ODNs). We tested their effectiveness in autoimmune B cells and interferon-alpha-producing dendritic cells in vitro and in lupus-prone MRL-Fas(lpr/lpr )mice in vivo. RESULTS: Class R INH-ODNs have 10- to 30-fold higher inhibitory potency when autoreactive B cells are synergistically activated through the BCR and associated TLR7 or 9 than when stimulation occurs via non-BCR-engaged TLR7/9. Inhibition of TLR9 requires the presence of both CCT and GGG triplets in an INH-ODN, whereas the inhibition of the TLR7 pathway appears to be sequence-independent but dependent on the phosphorothioate backbone. This difference was also observed in the MRL-Fas(lpr/lpr )mice in vivo, where the prototypic class R INH-ODN was more effective in curtailing abnormal autoantibody secretion and prolonging survival. CONCLUSIONS: The increased potency of class R INH-ODNs for autoreactive B cells and dendritic cells may be beneficial for lupus patients by providing pathway-specific inhibition yet allowing them to generate protective immune response when needed. BioMed Central 2009 2009-05-28 /pmc/articles/PMC2714127/ /pubmed/19476613 http://dx.doi.org/10.1186/ar2710 Text en Copyright © 2009 Lenert et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lenert, Petar
Yasuda, Kei
Busconi, Liliana
Nelson, Patrice
Fleenor, Courtney
Ratnabalasuriar, Radhika S
Nagy, Peter L
Ashman, Robert F
Rifkin, Ian R
Marshak-Rothstein, Ann
DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title_full DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title_fullStr DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title_full_unstemmed DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title_short DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr )mice in vivo
title_sort dna-like class r inhibitory oligonucleotides (inh-odns) preferentially block autoantigen-induced b-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone mrl-fas(lpr/lpr )mice in vivo
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2714127/
https://www.ncbi.nlm.nih.gov/pubmed/19476613
http://dx.doi.org/10.1186/ar2710
work_keys_str_mv AT lenertpetar dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT yasudakei dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT busconililiana dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT nelsonpatrice dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT fleenorcourtney dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT ratnabalasuriarradhikas dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT nagypeterl dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT ashmanrobertf dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT rifkinianr dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo
AT marshakrothsteinann dnalikeclassrinhibitoryoligonucleotidesinhodnspreferentiallyblockautoantigeninducedbcellanddendriticcellactivationinvitroandautoantibodyproductioninlupuspronemrlfaslprlprmiceinvivo